Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism

Type I diabetes (T1D) results from T cell-mediated damage of pancreatic β-cells and loss of insulin production. The cholinergic anti-inflammatory pathway represents a physiological link connecting the central nervous and immune systems via vagus nerve, and functions to control the release of proinfl...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Junu A., Bashir, Ghada, Qureshi, Mohammed M., Mohamed, Yassir A., Azzi, Jamil, al-Ramadi, Basel K., Fernández-Cabezudo, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061850/
https://www.ncbi.nlm.nih.gov/pubmed/27790217
http://dx.doi.org/10.3389/fimmu.2016.00419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061850/
https://www.ncbi.nlm.nih.gov/pubmed/27790217
http://dx.doi.org/10.3389/fimmu.2016.00419

Ejemplares similares